DVLT is trading at $0.49 (+6%) in pre-market, continuing its recent upward momentum. While broader market gains are providing a tailwind, the move also follows significant company-specific news from last week.
- On May 20, Datavault AI announced a binding term sheet with Wellgistics Health to form DelivMeds AI, a new healthcare platform venture.
- This venture includes the acquisition of intellectual property and a controlling stake in Tollo Health, marking a significant expansion into the digital health and pharmacy services sector.
- The stock is also benefiting from general risk-on sentiment, with major U.S. equity futures trading higher this morning.